Amdocs Limited (DOX) Expected to Post Quarterly Sales of $978.76 Million

Equities analysts expect Amdocs Limited (NASDAQ:DOX) to post sales of $978.76 million for the current fiscal quarter, according to Zacks Investment Research. Five analysts have issued estimates for Amdocs’ earnings. The lowest sales estimate is $974.75 million and the highest is $980.06 million. Amdocs posted sales of $954.73 million during the same quarter last year, which suggests a positive year over year growth rate of 2.5%. The firm is expected to report its next earnings results after the market closes on Tuesday, January 30th.

According to Zacks, analysts expect that Amdocs will report full-year sales of $978.76 million for the current year, with estimates ranging from $3.95 billion to $3.98 billion. For the next fiscal year, analysts forecast that the firm will post sales of $4.11 billion per share, with estimates ranging from $4.08 billion to $4.14 billion. Zacks’ sales averages are a mean average based on a survey of sell-side research analysts that follow Amdocs.

Amdocs (NASDAQ:DOX) last posted its earnings results on Wednesday, November 8th. The technology company reported $0.94 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.89 by $0.05. Amdocs had a net margin of 11.30% and a return on equity of 14.77%. The firm had revenue of $979.70 million for the quarter, compared to analysts’ expectations of $977.72 million. During the same quarter last year, the firm earned $0.89 EPS. The company’s quarterly revenue was up 4.2% compared to the same quarter last year.

A number of research firms recently commented on DOX. BidaskClub raised shares of Amdocs from a “strong sell” rating to a “sell” rating in a report on Thursday. Zacks Investment Research raised shares of Amdocs from a “sell” rating to a “hold” rating in a report on Tuesday. Oppenheimer reaffirmed a “buy” rating and issued a $77.00 price target on shares of Amdocs in a report on Thursday, December 14th. Robert W. Baird reaffirmed a “hold” rating and issued a $66.00 price target on shares of Amdocs in a report on Friday, October 20th. Finally, Jefferies Group reaffirmed a “hold” rating and issued a $70.00 price target on shares of Amdocs in a report on Thursday, October 12th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and two have issued a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus price target of $70.29.

Shares of Amdocs (NASDAQ DOX) opened at $69.61 on Friday. The company has a market cap of $9,902.74, a P/E ratio of 23.52, a P/E/G ratio of 2.36 and a beta of 0.52. Amdocs has a 1-year low of $56.10 and a 1-year high of $69.61.

Amdocs announced that its Board of Directors has initiated a share repurchase plan on Wednesday, November 8th that allows the company to buyback $800.00 million in outstanding shares. This buyback authorization allows the technology company to reacquire shares of its stock through open market purchases. Shares buyback plans are often a sign that the company’s board of directors believes its stock is undervalued.

The firm also recently announced a quarterly dividend, which was paid on Friday, January 19th. Shareholders of record on Friday, December 29th were issued a dividend of $0.22 per share. The ex-dividend date was Thursday, December 28th. This represents a $0.88 dividend on an annualized basis and a yield of 1.26%. Amdocs’s payout ratio is 29.73%.

A number of hedge funds have recently modified their holdings of the business. Bank of Hawaii raised its holdings in Amdocs by 4.2% during the 2nd quarter. Bank of Hawaii now owns 14,490 shares of the technology company’s stock valued at $934,000 after acquiring an additional 590 shares during the period. Robecosam AG grew its position in shares of Amdocs by 37.8% during the 2nd quarter. Robecosam AG now owns 2,550 shares of the technology company’s stock valued at $163,000 after purchasing an additional 700 shares in the last quarter. Janney Montgomery Scott LLC grew its position in shares of Amdocs by 3.9% during the 3rd quarter. Janney Montgomery Scott LLC now owns 22,490 shares of the technology company’s stock valued at $1,447,000 after purchasing an additional 835 shares in the last quarter. Park Avenue Securities LLC grew its position in shares of Amdocs by 14.2% during the 3rd quarter. Park Avenue Securities LLC now owns 6,857 shares of the technology company’s stock valued at $443,000 after purchasing an additional 855 shares in the last quarter. Finally, Intrepid Capital Management Inc. grew its position in shares of Amdocs by 0.3% during the 3rd quarter. Intrepid Capital Management Inc. now owns 324,451 shares of the technology company’s stock valued at $20,869,000 after purchasing an additional 875 shares in the last quarter. 92.05% of the stock is currently owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION WARNING: This piece was originally posted by American Banking News and is the property of of American Banking News. If you are viewing this piece on another domain, it was illegally copied and republished in violation of United States & international trademark & copyright legislation. The correct version of this piece can be accessed at https://www.americanbankingnews.com/2018/01/20/amdocs-limited-dox-expected-to-post-quarterly-sales-of-978-76-million-2.html.

About Amdocs

Amdocs Limited is a provider of software and services for communications, entertainment and media industry service providers. The Company develops, implements and manages software and services associated with business support systems (BSS), operational support systems (OSS) and network operations to enable service providers to introduce new products and services, process orders, monetize data, support new business models and enhance their understanding of their customers.

Get a free copy of the Zacks research report on Amdocs (DOX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Amdocs (NASDAQ:DOX)

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply